The largest database of trusted experimental protocols

Spark fluorescence plate reader

Manufactured by Tecan

The Spark fluorescence plate reader is a compact and versatile instrument designed for fluorescence-based assays. It provides accurate and reliable data acquisition across a wide range of microplate formats. The Spark fluorescence plate reader is a core tool for researchers and scientists working in various fields that require high-performance fluorescence detection.

Automatically generated - may contain errors

4 protocols using spark fluorescence plate reader

1

Quantifying GPCR-mediated IP1 signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Signaling assays were performed with receptor constructs harboring the wild-type helix 8 and the full-length C-terminus as well as the entire ICL3. Agonist-induced IP1 accumulation was measured in transiently transfected HEK293T/17 cells, as described before82 (link). Twenty-four hours after transfection, cells were washed with phosphate-buffered saline (PBS), detached with trypsin-EDTA (Sigma), and resuspended in assay buffer (10 mM HEPES pH 7.4, 1 mM CaCl2, 0.5 mM MgCl2, 4.2 mM KCl, 146 mM NaCl, 50 mM LiCl, 5.5 mM glucose, 0.1% (w/v) BSA). Cells were seeded at 20,000 cells per well in white 384-well plates (Greiner) and incubated for 2 h at 37 °C with a concentration range of phenylephrine (Tocris) diluted in assay buffer. IP1 accumulation was measured using the HTRF IP-One kit (Cisbio) according to the manufacturer’s protocol on a SPARK fluorescence plate reader (Tecan). This kit uses an anti-IP1 antibody labeled with Tb-cryptate as FRET-donor (excitation at 317 nm, emission at 620 nm) and IP1-d2 as FRET-acceptor (emission at 655 nm). The ratio of emission intensities of FRET-acceptor and FRET-donor (Em655 nm/Em620 nm) was calculated, and EC50 (median effective concentration) values were obtained by fitting the data with a three-parameter non-linear regression with GraphPad Prism Suite 8.4.3.
+ Open protocol
+ Expand
2

Transfected HEK293T Cell Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Signaling experiments were performed on whole cells with transiently transfected HEK293T cells as described before11 (link),14 (link). Twenty-four hours after transfection, cells were washed with PBS, detached with cell dissociation buffer (Gibco) and washed again in PBS. Cells were resuspended in assay buffer [10 mM Hepes (pH 7.4), 146 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, 4.2 mM KCl, 5.5 mM glucose, 50 mM LiCl, 1 mM 3-isobutyl-1-methylxanthin). cAMP and IP1 accumulation assays were performed on white low-volume 384-well plates (Greiner) using the cAMP Tb kit and the IP-One Tb kit (both from CisBio), respectively, according to the manufacturer’s protocol. For cAMP accumulation, 5000 cells were incubated with agonist at the indicated concentrations for 30 min at RT. To determine basal receptor signaling, cells were incubated in isobutylmethylxanthine (IBMX)-containing assay buffer for 30 min in the absence of ligand. For IP1 accumulation, 20,000 cells were incubated with agonist at the indicated concentrations for 2 h at 37 °C. Fluorescence intensities were measured on a Spark fluorescence plate reader (Tecan). To generate concentration-response curves, data were fitted to a three-parameter logistic equation.
+ Open protocol
+ Expand
3

SARS-CoV-2 Main Protease Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
IC50 values for inhibition of the recombinant
SARS-CoV-2 main protease were determined by an FRET assay using the
peptide Dabcyl-KTSAVLQ↓SGFRKM-E(Edans)-NH2 (Biosyntan)
as the substrate (↓ indicates the cleavage site). The assay
has been previously described,20 (link) but we
optimized both enzyme and substrate concentrations, as well as the
buffer composition, to achieve higher sensitivity. Mpro (50 nM) was dissolved in buffer containing 20 mM HEPES, 120 mM NaCl,
0.4 mM EDTA, 20% glycerol, pH 7.0. Then, 4 mM DTT was added just prior
to the measurements. The concentration of compounds 13b-K and 13b-H (in DMSO) was varied between 0 and 100 μM.
After incubation of the enzyme and compound for 10 min at 37 °C,
the reaction was initiated by adding the FRET substrate at a final
concentration of 10 μM to each well (final volume: 100 μL/well).
A Tecan Spark fluorescence plate reader was used, with an excitation
wavelength of 360 nm and an emission wavelength of 460 nm. GraphPad
Prism 9.2.0 software (GraphPad) was used for the calculation of the
IC50 values. Measurements of inhibitory activities of the
compounds were performed in triplicate and are presented as the mean
± SD.
+ Open protocol
+ Expand
4

SARS-CoV-2 Main Protease Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 main protease (Mpro) was recombinantly produced as described before [36 (link)]. Compounds were tested in a Förster resonance energy transfer (FRET) assay for inhibition of the SARS-CoV-2 Mpro. The peptide Dabcyl-KTSAVLQ↓SGFRKM-E(Edans)-NH2 (Biosyntan, Berlin, Germany) (↓ indicates the cleavage site), corresponding to the P7–P6′ residues of the nsp4–nsp5 processing site of the viral polyprotein pp1a/pp1ab, was used as the substrate. Quenching of the Edans fluorescence by the Dabcyl residue was eliminated after cleavage of the scissile bond between P1-Gln and P1′-Ser and the difference in fluorescence emission was measured with a Tecan Spark fluorescence plate reader, operated at an excitation wavelength of 360 nm and an emission wavelength of 460 nm.
Candidate compounds were kept in a DMSO stock solution; the Mpro was in a buffer containing 20 mM HEPES, 120 mM NaCl, 0.4 mM EDTA, 20% glycerol, pH 7.0. DTT (4 mM) was added to the buffer prior to running the assay. Following incubation of 50 nM SARS-CoV-2 Mpro with 100 µM of the candidate compound for 10 min at 37 °C, the reaction was initiated by the addition of 10 µM of the FRET substrate to each well. The final DMSO concentration was <2%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!